Compare BEAM & YELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BEAM | YELP |
|---|---|---|
| Founded | 2017 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | 2020 | 2012 |
| Metric | BEAM | YELP |
|---|---|---|
| Price | $26.19 | $31.11 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 5 |
| Target Price | ★ $48.09 | $32.00 |
| AVG Volume (30 Days) | ★ 1.9M | 1.1M |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 37.30 |
| EPS | N/A | ★ 2.25 |
| Revenue | $55,701,000.00 | ★ $1,466,918,000.00 |
| Revenue This Year | N/A | $5.87 |
| Revenue Next Year | $26.52 | $2.94 |
| P/E Ratio | ★ N/A | $13.78 |
| Revenue Growth | N/A | ★ 5.34 |
| 52 Week Low | $13.53 | $27.29 |
| 52 Week High | $35.25 | $41.72 |
| Indicator | BEAM | YELP |
|---|---|---|
| Relative Strength Index (RSI) | 53.22 | 60.45 |
| Support Level | $25.53 | $30.04 |
| Resistance Level | $27.87 | $30.94 |
| Average True Range (ATR) | 1.67 | 0.67 |
| MACD | -0.03 | 0.27 |
| Stochastic Oscillator | 49.36 | 89.69 |
Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.
Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making better buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States.